Login / Signup

Integrated analysis of FHIT gene alterations in cancer.

Lucía Simón-CarrascoElena PietriniAndrés J López-Contreras
Published in: Cell cycle (Georgetown, Tex.) (2024)
The Fragile Histidine Triad Diadenosine Triphosphatase ( FHIT ) gene is located in the Common Fragile Site FRA3B and encodes an enzyme that hydrolyzes the dinucleotide Ap3A. Although FHIT loss is one of the most frequent copy number alterations in cancer, its relevance for cancer initiation and progression remains unclear. FHIT is frequently lost in cancers from the digestive tract, which is compatible with being a cancer driver event in these tissues. However, FHIT loss could also be a passenger event due to the inherent fragility of the FRA3B locus. Moreover, the physiological relevance of FHIT enzymatic activity and the levels of Ap3A is largely unclear. We have conducted here a systematic pan-cancer analysis of FHIT status in connection with other mutations and phenotypic alterations, and we have critically discussed our findings in connection with the literature to provide an overall view of FHIT implications in cancer.
Keyphrases
  • papillary thyroid
  • copy number
  • squamous cell
  • genome wide
  • gene expression
  • mitochondrial dna
  • squamous cell carcinoma
  • lymph node metastasis
  • childhood cancer
  • transcription factor
  • nitric oxide
  • hydrogen peroxide